Kenvue Stock

$20.45

1.59% yesterday

NYSE, Sep 03, 10:09 pm CET

ISIN

US49177J1025

Symbol

KVUE

Reports

Quarter | Annual

Index

S&P 500

Sector

Household & Personal Products

Industry

Personal Care Products

Overview Dividends Analysts Charts News Strategies

Kenvue Stock price

$20.45

-6.45 23.98% 5Y

NYSE, Closing price Wed, Sep 03 2025

-0.33 1.59%

ISIN

US49177J1025

Symbol

KVUE

Reports

Quarter | Annual

Index

S&P 500

Sector

Household & Personal Products

Industry

Personal Care Products

Key metrics

Basic

Market capitalization

$39.2b

Enterprise Value

$46.8b

Net debt

$7.5b

Cash

$1.1b

Shares outstanding

1.9b

Valuation (TTM | estimate)

P/E

27.6 | 19.2

P/S

2.6 | 2.5

EV/Sales

3.1 | 3.0

EV/FCF

28.6

P/B

3.7

Dividends

DPS

$0.81

Yield 1Y | 5Y

3.9% | 1.1%

Growth 1Y | 5Y

102.5% | -

Payout 1Y | 3Y

150.0% | 47.6%

Increased

2 Years

Financials (TTM | estimate)

Revenue

$15.1b | $15.5b

EBITDA

$3.2b | $3.7b

EBIT

$2.6b | $3.1b

Net Income

$1.4b | $2.0b

Free Cash Flow

$1.6b

Growth (TTM | estimate)

Revenue

-2.2% | 0.1%

EBITDA

-8.3% | 3.9%

EBIT

-9.8% | 3.9%

Net Income

26.7% | 98.1%

Free Cash Flow

-7.8%

Financial Health

Equity Ratio

37.8%

Return on Equity

10.7%

ROCE

12.5%

ROIC

8.1%

Debt/Equity

0.8

EPS

$0.7

FCF per Share

$0.9

Short interest

3.1%

Employees

22k

Rev per Employee

$700.0k

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Get Started for Free Today

Kenvue Stock Analysis

Unlock Scores for Free

??

24 Analysts have issued a Kenvue forecast:

9x Buy

38%

15x Hold

63%

More details on Analyst Estimates Including Price Targets

24 Analysts have issued a Kenvue forecast:

Buy

38%

Hold

63%

Analyst Estimates with Stock Price Targets

Financial data from Kenvue

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	15,141 15,141	2% 2% 100%
- Direct Costs	6,322 6,322	3% 3% 42%
Gross Profit	8,819 8,819	2% 2% 58%
- Selling and Administrative Expenses	5,758 5,758	2% 2% 38%
- Research and Development Expense	393 393	6% 6% 3%
EBITDA	3,243 3,243	8% 8% 21%
- Depreciation and Amortization	610 610	1% 1% 4%
EBIT (Operating Income) EBIT	2,633 2,633	10% 10% 17%
Net Profit	1,418 1,418	27% 27% 9%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Kenvue Stock News

Positive

Seeking Alpha

●

7 days ago

Best Dividend Aristocrats For September 2025

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return...

Positive

The Motley Fool

●

14 days ago

Sender Buys Into the Turnaround Story at Kenvue

According to an SEC filing published August 15, 2025, Sender Co & Partners, Inc. increased its position in Kenvue (KVUE 0.65%) by 530,717 shares. The estimated trade value, based on the period's average share price, was approximately $12.08 million.

Negative

Seeking Alpha

●

16 days ago

Kenvue Can't Be Written Off Yet

Kenvue's fundamental performance looks disastrous, with revenue and margins going in the wrong direction. In that context, a 20x-plus multiple to 2025 adjusted EPS looks far too high. But a new board, new leadership, and new strategy suggest real change is on the way for a business where execution clearly is a concern.

More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office	United States
CEO	Thibaut Mongon
Employees	22,000
Website	www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now